Abstract
Community health workers (CHWs) can play a key role in malaria elimination through expanding access to malaria testing and treatment. The Dominican Republic, a low endemic country committed to eliminate malaria by 2025, implemented a structured malaria CHW network in the three main urban foci of Greater Santo Domingo. This research quantifies the networks’ contributions towards malaria elimination from its implementation in 2019 until 2022. The study highlights the impact of COVID-19 disruptions on CHWs’ performance and explores the network’s ability to bounce back from health systems’ shocks.
The performance of a malaria CHW network in Greater Santo Domingo, Dominican Republic was evaluated using weekly data collected from CHWs and routinely collected surveillance data from the Ministry of Public Health (MoH). We assess performance of CHWs by analyzing key variables such as (1) reporting compliance, (2) household visitation rates, (3) malaria rapid diagnostic tests performed, (4) malaria cases detected, and (5) time between symptom onset and malaria diagnosis. To evaluate the impact of COVID-19 on the network, CHW’s performance indicators are evaluated across three time periods (prior to, during, and after COVID-19 interruptions).
Results showed that over the evaluation period, reported malaria cases in study foci decreased from 1,243 cases in 2019 to 5 cases in 2023. CHWs diagnosed and treated over 43% of malaria cases in study foci before COVID-19 interruptions and 14% during interruptions. 83% of cases detected by CHWs were detected through active case detection, with 17% detected passively. CHWs detected malaria cases and initiated treatment 1.5 days earlier than health facilities and MoH personnel performing active case detection.
This evaluation provides evidence that a structured CHW network with clearly defined responsibilities and management protocol can assume a large proportion of malaria case management service provision, contribute to early malaria case detection, and help curb local malaria transmission. It adds to a growing body of research on the feasibility and benefits of CHW-led proactive household visitation. Despite interruptions such as the COVID-19 pandemic, concerted investment can sustain CHW program gains.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation INV-002736. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The Clinton Health Access Initiative, with funds from the Bill and Melinda Gates Foundation, covered the cost of SurveyCTO, the platform used to collect CHW data, CHW initial trainings and implementation cost. The Bill & Melinda Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research did not require IRB approval as it is based on routinely collected data by the Ministry of Health and does not include any personal information. The data used is anonymized and publicly available, ensuring compliance with ethical standards and privacy regulations.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used to generate this article is available at the Figshare repository with DOI https://doi.org/10.6084/m9.figshare.26124820.v1 This project contains twelve files: (1) 2019-2022 DR Malaria program confirmed case dataset - Anonymized, RAW DATA: Contains raw data on confirmed malaria cases collected by the National Malaria Program from 2019 to 2022. (2) 2019-2022 DR Malaria program confirmed case dataset - Anonymized, DATA DICTIONARY: is the data dictionary explaining the meaning of each variable in the “2019-2022 DR Malaria program confirmed case” dataset. (3) 2019-2022 Malaria risk stratification case data dataset - Anonymized, RAW DATA: contains raw data from 2019 to 2022 on indigenous malaria confirmed cases, used by the national malaria program for malaria risk stratification. (4) 2019-2022 Malaria risk stratification case data dataset - Anonymized, DATA DICTIONARY: is the data dictionary explaining the meaning of each variable in the “2019-2022 Malaria risk stratification case data” dataset. (5) 2019-2022 Weekly La Cienaga and San Cristobal monitoring and evaluation dataset (dr-monitoreosemanal) - Anonymized, RAW DATA: contains raw data on La Cienaga and San Cristobal community health worker performance from 2019-2022. (6) 2019-2022 Weekly La Cienaga and San Cristobal monitoring and evaluation dataset (dr-monitoreosemanal) - Anonymized, DATA DICTIONARY: is the data dictionary explaining the meaning of each variable in the “2019-2022 Weekly La Cienaga and San Cristobal monitoring and evaluation” dataset. (7) 2019-2022 Weekly Los Tres Brazos monitoring and evaluation dataset (dr3b-monitoreosemanal) - Anonymized, RAW DATA: contains raw data on Los Tres Brazos community health worker performance from 2019-2022. (8) 2019-2022 Weekly Los Tres Brazos monitoring and evaluation dataset (dr3b-monitoreosemanal) - Anonymized, DATA DICTIONARY: is the data dictionary explaining the meaning of each variable in the “2019-2022 Weekly Los Tres Brazos monitoring and evaluation” dataset. (9) 2019-2022 Weekly La Cienaga and San Cristobal confirmed case dataset (dr-casosconfirmados) - Anonymized, RAW DATA: contains raw data on malaria confirmed cases detected by community health workers in La Cienaga and San Cristobal from 2019 to 2022. (10) 2019-2022 Weekly La Cienaga and San Cristobal confirmed case dataset (dr-casosconfirmados) - Anonymized, DATA DICTIONARY: is the data dictionary explaining the meaning of each variable in the “2019-2022 Weekly La Cienaga and San Cristobal confirmed case” dataset. (11) 2019-2022 Weekly Los Tres Brazos confirmed case dataset (dr3b-casosconfirmados) - Anonymized, RAW DATA: contains raw data on malaria confirmed cases detected by community health workers in Los Tres Brazos from 2019 to 2022. (12) 2019-2022 Weekly Los Tres Brazos confirmed case dataset (dr3b-casosconfirmados) - Anonymized, DATA DICTIONARY: is the data dictionary explaining the meaning of each variable in the “2019-2022 Weekly Los Tres Brazos confirmed case” dataset.
